Spectral Medical Inc T.EDT

But, who will make all the empty promises..

[hmmmmmmmm]

if Kellum goes? 

Nov. 12 2021

Dr. John Kellum, Chief Medical Officer of Spectral, commented, “We remain focused on the start of our DIMI usability trial for home use of this exciting new device aimed at a $5.3 billion U.S. home dialysis market. We had anticipated first patient enrollment into the DIMI usability trial at the beginning of Q4 2021, but now expect to begin the trial in Q1 2022

 

May 13 2022

Dr. John Kellum, Chief Medical Officer of Spectral, further noted, “We continue to advance the development and commercialization of our SAMI and DIMI devices through our Dialco Medical subsidiary. We remain focused on the start of our DIMI usability trial for home use and we expect first patient enrollment in the third quarter of 2022 with a study duration of approximately 18 months…”

[mercedesman]

Jettison the KOL (mainly there for PMX/EAA) and you likely have bigger problems. He's an academic and not a businessman.  Suggests that he needs to be reigned in and held to task by the Prez who should know investors are listenting...and if the Prez can't do it, then the BoD needs to step in.  Someone needs to own up to past mistakes & mistatements...or credibility will be

[hmmmmmmmm]

I'd agree Kellum was brought on mainly for PMX, but his promises/ quotes on that front are just as far off. (incoming) I'd also agree he's an academic, and that has clearly not translated into delivering anything close to acceptable enrollment numbers for PMX. A departure would turn me into a buyer, as it would be a clear sign the company is correcting course. Which it must.